RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Acoustic Holograms for Bilateral Blood-Brain Barrier Opening in a Mouse Model
[EN] Transcranial focused ultrasound (FUS) in conjunction with circulating microbubbles injection is the sole non-invasive technique that temporally and locally opens the blood-brain barrier (BBB), allowing targeted drug delivery into the central nervous system (CNS). However, single-element FUS technologies do not allow the simultaneous targeting of several brain structures with high-resolution, and multi-element devices are required to compensate the aberrations introduced by the skull. In this work, we present the first preclinical application of acoustic holograms to perform a bilateral BBB opening in two mirrored regions in mice. The system consisted of a single-element focused transducer working at 1.68 MHz, coupled to a 3D-printed acoustic hologram designed to produce two symmetric foci in anesthetized mice in vivo and, simultaneously, compensate the aberrations of the wavefront caused by the skull bones. T1-weighed MR images showed gadolinium extravasation at two symmetric quasi-spherical focal spots. By encoding time-reversed fields, holograms are capable of focusing acoustic energy with a resolution near the diffraction limit at multiple spots inside the skull of small preclinical animals. This work demonstrates the feasibility of hologram-assisted BBB opening for low-cost and highly-localized targeted drug delivery in the CNS in symmetric regions of separate hemispheres., This work was supported in part by the Spanish Ministry of Science, Innovation, and Universities (MICINN) through Grants "Juan de la Cierva -Incorporacion" IJC2018-037897-I, and PID2019-111436RB-C22, in part by the Agencia Valenciana de la Innovacio through Grants INNVAL10/19/016, INNCON/2021/8, and INNVA1/2020/92, in part by Generalitat Valenciana through Grants ACIF/2017/045, AICO/2020/268, and BEFPI/2019/075, and in part by the National Institutes of Health through Grants 5R01EB009041 and 5R01AG038961. Action co-financed by the European Union through the Programa Operativo del Fondo Europeo de Desarrollo Regional (FEDER) of the Comunitat Valenciana (IDIFEDER/2018/022 and IDIFEDER/2021/004)
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-111436RB-C22
,
Generalitat Valenciana BEFPI/2019/075
,
National Institutes of Health 5R01EB009041
,
EEUU 5R01AG038961
,
National Institutes of Health INNVAL10/19/016
,
EEUU ACIF/2017/045
,
Agència Valenciana de la Innovació IDIFEDER/2018/022
,
Generalitat Valenciana IJC2018-037897-I
,
EDUC.INVEST.CULT.DEP INNVA1/2020/92
,
Agencia Estatal de Investigación AICO/2020/268
,
AGENCIA VALENCIANA DE LA INNOVACION INNCON/2021/8